baber/WOPTO huggingface dataset:
Patent AU-2012212094-B2 (AU)
Title: Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
Inventor: WEERS JEFFRY
IPC: A61K9/14
Filed: 2012-02-03
Granted: 2016-02-11
Abstract: Dry powder formulations for inhalation comprising spray-dried particles and their use in the treatment of an obstructive or inflammatory airways disease. Each particle has a core of a first active ingredient in substantially crystalline form that is coated with a layer of a second active ingredient in substantially amorphous form that is dispersed in a pharmaceutically acceptable hydrophobic excipient. A process for preparing such formulations is also described.
Patent AU-2012229123-B2 (AU)
Title: Methods of treating breast cancer with anthracycline therapy
Inventor: PEROU CHARLES M
IPC: A61K31/704
Filed: 2012-03-15
Granted: 2017-02-02
Abstract: The application describes methods for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including an anthracycline. The application also describes methods for treating subjects with breast cancer by screening them for the likelihood of the effectiveness of treating the cancer with a therapy including anthracycline and administering the therapy in subjects when it is found that anthracycline is likely to be effective.
Patent AU-2012238323-B2 (AU)
Title: Oriented Contact Lens with Brightly Colored Sclera
Inventor: BOWERS ANGIE
IPC: B29D11/00
Filed: 2012-10-11
Granted: 2014-08-28
Abstract: Oriented contact lenses have patterns in which the portion that substantially lies over the sclera when worn on-eye is brightly colored or tinted; the colored or tinted contact lenses can have colored or tinted central portions that enhance the iris when worn on-eye and limbal rings that enhance the limbus.
Patent AU-2012263093-B2 (AU)
Title: Audio-encoding method and apparatus, audio-decoding method and apparatus, recording medium thereof, and multimedia device employing same
Inventor: POROV ANTON
IPC: G10L19/02
Filed: 2012-06-01
Granted: 2016-08-11
Abstract: According to the present invention, an audio-encoding method comprises the steps of: for an audio spectrum, acquiring an envelope on a predetermined sub-band basis; quantizing the envelope on said sub-band basis; and obtaining a difference value between quantized envelopes of an adjacent sub-band, and performing lossless encoding on the difference value of the current sub-band using, as a context, the difference value of the previous sub-band. According to the present invention, the number of bits used for encoding envelope information of an audio spectrum in a limited bit range may be reduced, thereby increasing the number of bits used for encoding actual spectrum components.
Patent AU-2012275315-B2 (AU)
Title: Method of administration and treatment
Inventor: AUGER KURT R
IPC: A61K38/00
Filed: 2012-06-28
Granted: 2015-12-03
Abstract: This invention relates to a method of treating cancer in a human in need thereof, comprising determining the presence or absence of a detectable amount of a gene product of the Neurofibromin-2 (NF2) gene in a sample from said human, and administering to said human an effective amount of a focal adhesion kinase (FAK) inhibitor, or a pharmaceutically acceptable salt thereof, if no gene product or no isoform 1 gene product is detected. This invention also relates to a method of treating cancer in a human in need thereof, comprising determining the presence or absence of a detectable amount of a functional isoform 1 protein of the NF2 gene, or a functional fragment thereof, in a sample from said human, and administering to said human an effective amount of a focal adhesion kinase (FAK) inhibitor, or a pharmaceutically acceptable salt thereof, if no gene product or no isoform 1 gene product is detected.
Patent AU-2012301503-B2 (AU)
Title: Sentient environment
Inventor: BARKAY TAIR
IPC: G06Q50/12
Filed: 2012-08-06
Granted: 2016-12-08
Abstract: An embodiment of the invention provides a sentient environment which interacts with and adapts itself to a person present in the environment responsive to active and/or passive expressions of preferences by the person. Active communications are communications intentionally generated by the person using a communication terminal and intentionally generated by the person using a communication terminal and intentionally transmitted to the sentient environment via a communication system. Passive communications are communications generated responsive to the person's features, and/or gestures that are not intentionally made to communicate with the sentient environment.
Patent AU-2012331692-B2 (AU)
Title: Composition for improving neuropsychological test battery score
Inventor: GROENENDIJK MARTINE
IPC: A61K45/06
Filed: 2012-10-30
Granted: 2017-03-02
Abstract: The invention relates to a composition comprising: (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA),or esters thereof, for use in the improvement of the composite NTB score. The invention also provides an improved NTB method comprising an optimized set of individualized tests, in particular for a (prodromal or mild) Alzheimer's or dementia patient.
Patent AU-2012362592-B2 (AU)
Title: Oven for fiber heat treatment
Inventor: BAGWELL RENEE M
IPC: F24F9/00
Filed: 2012-12-21
Granted: 2016-01-07
Abstract: An improved oven (1) comprising a conveyor configured and arranged to move a product (11) to be processed through an oven, a primary air delivery system (45) configured and arranged to provide a heated primary air flow (47), a secondary air delivery system configured and arranged to provide a heated secondary air flow (48), a processing enclosure (21) configured and arranged to receive and contain the product and the primary air flow, an insulated enclosure (2) configured and arranged to receive the heated secondary air flow, the processing enclosure configured and arranged to extend through the insulated enclosure and the heated secondary air flow and to separate the primary air flow from the secondary air flow.
Patent AU-2013203772-B2 (AU)
Title: Purification of cell culture derived alpha1 protease inhibitor
Inventor: OWNBY DAVID
IPC: C07K1/14
Filed: 2013-04-11
Granted: 2015-01-22
Abstract: Described herein are methods for purifying recombinant, cell culture derived alphal-protease inhibitor and removing a colored species that co-purifies with the recAlPI protein. Also described are methods for reducing the iron in cell culture derived alphal-protease inhibitor. (7311426 1):MRR
Patent AU-2013204621-B2 (AU)
Title: Apparatus and Methods for Hemodialysis
Inventor: KAMEN DEAN
IPC: A61M1/10
Filed: 2013-04-12
Granted: 2015-12-03
Abstract: An enclosure for containing a hemodialysis unit includes a housing (51) suitable to support components for performing hemodialysis including a dialyzer (14), one or more pumps to circulate blood through the dialyzer, a source of dialysate, and one or more pumps to circulate the dialysate through the dialyzer. The housing may have a front panel (511) at which blood circuit connections and dialysate fluidic connections are located, e.g., blood line connections for patient blood access, connections for a reagent supply, dialyzer connections for both blood flow and dialysate, etc. The enclosure may also include a pair of vertical, side-by-side doors (53) hingedly mounted to the housing. With the doors in the closed position, access to the patient access and dialysate fluidic connections may be blocked, and the doors may allow for the retention of heat in the housing suitable for disinfection during a disinfection cycle.
Patent AU-2013216847-B2 (AU)
Title: Aqueous pharmaceutical composition with enhanced stability
Inventor: MEADOWS DAVID L
IPC: A61K9/00
Filed: 2013-02-08
Granted: 2016-06-23
Abstract: The present invention is an aqueous pharmaceutical composition that includes an ionized therapeutic agent, an ionic component and guar gum. The guar gum is present in the composition a concentration sufficient to limit interactions between the ionized therapeutic agent and the ionic component thereby imparting stability to the composition. The composition is preferably at or near physiologic pH. The aqueous pharmaceutical composition has been found particularly useful as an aqueous ophthalmic, otic or nasal composition. The pharmaceutical composition, due to its characteristics, is particularly suitable as an ophthalmic composition.
Patent AU-2013226038-B2 (AU)
Title: Method for providing support services using multi-channel navigator and route sequences
Inventor: TUCHMAN KENNETH D
IPC: H04M3/523
Filed: 2013-02-28
Granted: 2016-04-14
Abstract: A service center receives a command from a remote device over a network, where the service center provides support services to users on products on behalf clients. Based on the command, a context element of a route sequence map associated with a user of the remote device is identified, where the identified context element is one of context elements of the route sequence map in a hierarchical structure. Each context element having one or more property values specifying at least one of an action to be performed by the service center and a link to one or more child context elements. It is determined whether the identified context element is an action context element or a navigation context element based on one or more property values associated with the identified context element. If so, an action specified by the identified context is performed.
Patent AU-2013240842-B2 (AU)
Title: Process of preparing solifenacin or salt thereof, and novel intermediate used in the process
Inventor: LEE BYOUNG SUK
IPC: C07D453/02
Filed: 2013-03-21
Granted: 2015-09-03
Abstract: Disclosed herein is a method of preparing solifenacin or a salt thereof, including the steps of: (a) reacting (R)-quinuclidinol with bis(pentafluorophenyl)carbonate in an organic solvent to prepare a solifenacin intermediate,(3R)-1-azabicyclo[2,2,2]oct-3-yl pentafluorophenylcarbonate, and (b) reacting the solifenacin intermediate with (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline in an organic solvent to prepare solifenacin. The method is advantageous in that high-purity solifenacin or a salt thereof can be simply and efficiently prepared with high yield using a novel intermediate.
Patent AU-2013242899-B2 (AU)
Title: Telecommunications enclosure and organizer
Inventor: AZNAG MOHAMED
IPC: G02B6/44
Filed: 2013-03-21
Granted: 2017-04-20
Abstract: A closure (10) includes a cover (4) and seal block (18). A feeder cable pathway and rear cover is provided for separation of feeder cables from drop cables. The organizer (426) in the closure includes an end cap and rear cable storage (190). Cable fixation clips, linear or bendable, can be used individually or daisy chained together. Cable fixation chambers (224, 226) are positioned on top of the gel block (220) housing. The organizer is a click together organizer. Dual heights on cable guides on sides of the groove plate facilitate cable installation. Tray supports with rounded ends prevent looseness of the tray mounts. Other organizers include cable routing features for compact storage.
Patent AU-2013276084-B2 (AU)
Title: Method for detecting and identifying enterohemorrhagic Escherichia coli
Inventor: FACH PATRICK
IPC: C12Q1/68
Filed: 2013-06-14
Granted: 2019-04-04
Abstract: The invention relates to methods for predicting whether a sample contains en teroh em orrhagi c Escherichia coli (EHEC) of at least one of EH EC 0157:[H7], 0145:[H28], O103:[H2], 0111 :[H8], 0121 :[H19], 026: [H11], 045:[H2] or O104:[H4] serotypes, and for identifying said serotypes, through detection of gene espK in association with at least one of the genetic markers
Patent AU-2013283037-B2 (AU)
Title: Catalyst supports made from silicon carbide covered with TiO2 for fischer-tropsch synthesis
Inventor: LIU YUEFENG
IPC: B01J21/06
Filed: 2013-06-24
Granted: 2017-05-25
Abstract: A method for preparing a catalyst support made from SiC at least partially covered with TiO2, characterised in that said method comprises the following steps: (a) supplying a support made from β-SiC of high porosity, (b) preparing a solution of at least one precursor of TiO2, (c) impregnating said support with said solution, (d) drying said impregnated support, (e) calcining said impregnated support to transform said precursor of TiO2 into TiO2. With an active phase of iron or cobalt, this catalyst is suitable for the Fischer-Tropsch reaction.
Patent AU-2013289204-B2 (AU)
Title: Methods of inducing anesthesia
Inventor: BROSNAN ROBERT J
IPC: A61K31/015
Filed: 2013-03-14
Granted: 2018-05-10
Abstract: The present invention provides methods for determining the selectivity of an anesthetic for an anesthetic-sensitive receptor by determining the molar water solubility of the anesthetic. The invention further provides methods for modulating the selectivity of an anesthetic for an anesthetic-sensitive receptor by altering or modifying the anesthetic to have higher or lower water solubility. The invention further provides methods of inducing anesthesia in a subject by administering via the respiratory pathways (e.g., via inhalational or pulmonary delivery) an effective amount of an anesthetic compound identified according to the present methods.
Patent AU-2013292357-B2 (AU)
Title: Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated disease and conditions
Inventor: BARRETT STEPHEN DOUGLAS
IPC: A61P27/02
Filed: 2013-07-19
Granted: 2017-02-02
Abstract: Disclosed herein are compounds of formula (I) and therapeutic methods of treatment with compounds of formula (I), wherein L
Patent AU-2013312352-B2 (AU)
Title: Engineered transgene integration platform (ETIP) for gene targeting and trait stacking
Inventor: COGAN NOEL
IPC: A01H5/00
Filed: 2013-09-06
Granted: 2019-03-14
Abstract: An Engineered Transgene Integration Platform (ETIP) is described that can be inserted randomly or at targeted locations in plant genomes to facilitate rapid selection and detection of a GOI that is perfectly targeted (both the 5' and 3' ends) at the ETIP genomic location. One element in the subject disclosure is the introduction of specific double stranded breaks within the ETIP. In some embodiments, an ETIP is described using zinc finger nuclease binding sites, but may utilize other targeting technologies such as meganucleases, CRISPRs, TALs, or leucine zippers. Also described are compositions of, and methods for producing, transgenic plants wherein the donor or payload DNA expresses one or more products of an exogenous nucleic acid sequence (e.g. protein or RNA) that has been stably-integrated into an ETIP in a plant cell. In embodiments, the ETIP facilitates testing of gene candidates and plant expression vectors from ideation through Development phases.
Patent AU-2013331076-B2 (AU)
Title: Energy management by dynamic functionality partitioning
Inventor: MYRBERG MATS ERIC
IPC: G06F1/32
Filed: 2013-10-18
Granted: 2018-07-12
Abstract: A sensor and processing system dynamically partitions or allocates functionality between various remote sensor nodes and a processing subsystem based on energy management management considerations. Redundant functionality is located at the processing subsystem and each of the various remote sensor nodes, and each sensor node coordinates with the processing subsystem to determine the location (e.g., at the processing subsystem or at the sensor node) at which a particular functionality is executed.
Patent AU-2013331449-B2 (AU)
Title: Electrochemical energy storage devices
Inventor: BRADWELL DAVID J
IPC: H01M4/02
Filed: 2013-10-15
Granted: 2018-07-12
Abstract: Provided herein are energy storage devices. In some cases, the energy storage devices are capable of being transported on a vehicle and storing a large amount of energy. An energy storage device is provided comprising at least one liquid metal electrode, an energy storage capacity of at least about 1 MWh and a response time less than or equal to about 100 milliseconds (ms).
Patent AU-2013341439-B2 (AU)
Title: Container with a removable measuring cap
Inventor: DOUBLES ALLISON
IPC: B65D41/26
Filed: 2013-11-05
Granted: 2017-02-02
Abstract: A container for dispensing a liquid concentrate comprises a container body with top edge and a cap base sealed relative to the top edge. The cap base includes a wall having an inner thread, a funnel surrounding an opening, and a spout. The container includes a cap top with a shoulder including a flange having an outer thread and depending downwardly from the shoulder to define a channel being open toward a bottom edge of the cap top and located between an interior of the flange and the sidewall of the cap top. The cap top can be threadingly engaged to the cap base to form an outer seal between at least one of the shoulder and the flange of the cap top and the wall of the cap base and form an inner seal between the bottom edge of the sidewall of the cap top and the funnel of the cap base.
Patent AU-2013359383-B2 (AU)
Title: Controlling sex of oviparous embryos using light
Inventor: GRAJCAR ZDENKO
IPC: A01K41/00
Filed: 2013-12-11
Granted: 2018-03-01
Abstract: The sex of embryos in eggs is influenced or controlled through the application of light having selected wavelengths in order to promote the development of embryos of a selected sex. An incubating device is provided having an interior cavity that can be sealed from an outside, and having a plurality of lighting elements disposed on each of a plurality of trays disposed in the interior cavity. Eggs are disposed on the trays, and pre-determined environmental conditions are applied to the interior cavity to promote hatching of the eggs. Concurrently with the application of the environmental conditions, the eggs are irradiated according to pre-determined lighting conditions. The lighting conditions include applying light having wavelengths substantially concentrated in selected ranges, such as light wavelengths within the 390-419 nm, 410-450 nm, 420-450 nm, 450-495 nm, or other narrow range.
Patent AU-2013397705-B2 (AU)
Title: Hydrophobic alkali soluble emulsion thickener
Inventor: FAN LIQIANG
IPC: C08F216/16
Filed: 2013-08-09
Granted: 2017-10-12
Abstract: Hydrophobic alkali soluble emulsion is provided, which comprises a copolymer obtainable by polymerization with the following monomer components: a) an ethylenically unsaturated carboxylic acid monomer, b) an ethylenically unsaturated nonionic monomer, c) a nonionic macromonomer, and d) a methyl polyglycol acrylic acid ester.
Patent AU-2014206141-B2 (AU)
Title: Pressure cast concrete or mortar lined steel pipes and methods of making the same
Inventor: KUBAT PAUL
IPC: F16L58/06
Filed: 2014-07-23
Granted: 2016-07-21
Abstract: PRESSURE CAST CONCRETE OR MORTAR LINED STEEL PIPES AND METHODS OF MAKING THE SAME Pressure cast lined steel pipes (10) comprise an annular concrete or mortar liner (14) along an inside diameter, and a metal shell (12) surrounding the liner (14), wherein the liner (14) is in direct contact with the metal shell (12). The wall thickness of the liner (14) can be from 10 to 50 times the thickness of the metal shell (12). The pipe (10) may be coated with a dielectric material. A mold assembly used to form the pipe (10) includes an annular concrete or mortar composition chamber (46) formed between the metal shell (12) and an inner mold member (52). Pressurized water is used in the mold assembly to pressurize the concrete or mortar composition and exert a desired pressure force onto the metal shell (12) while the composition cures in the mold. Once a desired degree of cure is achieved, the pressure is removed causing the metal shell (12) to exert a desired compression force onto the cured liner.
Patent AU-2014218371-B2 (AU)
Title: Systems and methods for improving efficiency of electrosurgical generators
Inventor: GILBERT JAMES A
IPC: H03L5/02
Filed: 2014-08-26
Granted: 2018-11-01
Abstract: SYSTEMS AND METHODS FOR IMPROVING EFFICIENCY OF ELECTROSURGICAL GENERATORS A method of improving efficiency of an electrosurgical generator (110) is presented, the method including controlling an output of an electrosurgical generator (110) by converting a direct current (DC) to an alternating current (AC) using an inverter (232), and sensing a current and a voltage at an output of the inverter (232). The method further includes the steps of determining a power level based on the sensed voltage and the sensed current, determining an efficiency of the electrosurgical generator (110), and inserting a predetermined integer number of off cycles when the efficiency of the electrosurgical generator (110) reaches a threshold power efficiency.
Patent AU-2014222418-B2 (AU)
Title: Enhanced stability of novel liquid compositions
Inventor: AGISIM GARY ROBERT
IPC: A61K9/48
Filed: 2014-02-13
Granted: 2016-06-23
Abstract: The present invention relates to compositions of pharmaceutical agents in combination with additional pharmaceutical agents in a mixture of polyethylene glycol, polyvinylpyrrolidone, and propylene glycol and a process of making the compositions.
Patent AU-2014232252-B2 (AU)
Title: Current sensing multiple output current stimulators with fast turn on time
Inventor: LEE EDWARD K F
IPC: A61N1/36
Filed: 2014-03-17
Granted: 2018-01-18
Abstract: A multiple output current stimulator circuit with fast turn on time is described. At least one pair of input side and output side transistors is arranged in a current mirror connected to a supply transistor by cascode coupling. The output side transistor supplies stimulation current to an electrode in contact with tissue. An operational amplifier connected to a reference voltage and to the output side transistor drives the supply transistor to maintain the voltage at the output side transistor equal to the reference voltage. The at least one pair of transistors includes multiple pairs of transistors whose output side transistors drive respective electrodes with stimulation currents. The stimulator determines the initiation and duration of stimulation current pulses supplied to each electrode. At circuit activation, large currents are generated which discharge capacitances in the output side transistors causing rapid output side transistor turn on.
Patent AU-2014244375-B2 (AU)
Title: Urinary catheters with protective tip
Inventor: HANNON DAVID
IPC: A61M25/00
Filed: 2014-03-13
Granted: 2016-09-22
Abstract: A protective catheter tip (78) has a generally tubular body portion (84) defining an interior cavity (82). The proximal end of a urinary catheter (92) is at least partially received within the protective tip, with the protective tip being retained on the urinary catheter without the need for a sleeve connecting the protective tip and the catheter. The protective tip may include a projection (80, 80a) received within a draining hole or eye (90, 90a) at the proximal end of the catheter to retain the protective tip on the catheter. The protective tip (48) may instead include one or more projections (58) that apply a frictional force to an outer surface of the catheter to retain the protective tip on the catheter. The protective tip (60) may instead be retained on the catheter (62) by a tether (66) extending between the protective tip and a distal end of the catheter. The protective tip (104) may also be provided in two pieces (106, 108).